AsiaMedic Limited Completes Selective Capital Reduction
AsiaMedic Limited has completed its Proposed Selective Capital Reduction, effective June 9, 2025, reducing its issued share capital to S$33,394,437 with 1,129,522,270 ordinary shares. This move, approved by shareholders, aims to streamline the company's financial structure and enhance shareholder value. AsiaMedic operates in the healthcare sector in Singapore, with a current market cap of S$13.85M.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Asiamedic Limited ( (SG:505) ).
AsiaMedic Limited has successfully completed its Proposed Selective Capital Reduction, effective as of June 9, 2025. This move, which was approved by shareholders and met all regulatory requirements, reduces the company’s issued and fully paid-up share capital to S$33,394,437, comprising 1,129,522,270 ordinary shares. The completion of this capital reduction is expected to streamline the company’s financial structure, potentially enhancing shareholder value.
More about Asiamedic Limited
AsiaMedic Limited, incorporated in Singapore, operates in the healthcare industry, focusing on providing medical and healthcare services through its subsidiaries.
Average Trading Volume: 761,505
Technical Sentiment Signal: Sell
Current Market Cap: S$13.85M
For a thorough assessment of 505 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- How will the Trump-Musk Rift Impact Tesla Stock? One Investor Weighs In
- Meta Is Making a Big Bold Investment of Over $10B in Scale AI
- ‘Keep an Eye on the Bigger Picture,’ Says Morgan Stanley About Tesla Stock
Disclaimer & Disclosure
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue